Indication
MIBG Avid Tumors
1 clinical trial
1 drug
Clinical trial
A Phase II Study of <131>I-Metaiodobenzyguanidine (<131>I-MIBG) Therapy for Patients With MIBG Avid TumorsStatus: Active (not recruiting), Estimated PCD: 2025-03-01
Drug
MIBG1 clinical trial
1 drug